Search research articles
Contact Us
Filters
Showing results (221-230 of 230) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 230 results.
JAMA Oncology
|
March 9, 2023
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial
Tufia C Haddad, Vera J Suman, Antonino B D'Assoro, et al.
Cancer
|
April 25, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot
Amye J Tevaarwerk, Dhauna Karam, Clare A Gatten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
Siddhartha Yadav, Chunling Hu, Steven N Hart, et al.
Breast Cancer Research : BCR
|
January 31, 2024
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer
Filipa Lynce, Laura E Stevens, Zheqi Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2022
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
Erica L Mayer, Christian Fesl, Dominik Hlauschek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2021
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
Michael Gnant, Amylou C Dueck, Sophie Frantal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
Angela DeMichele, Douglas Yee, Donald A Berry, et al.
The New England Journal of Medicine
|
July 14, 2016
Adaptive Randomization of Neratinib in Early Breast Cancer
John W Park, Minetta C Liu, Douglas Yee, et al.
The New England Journal of Medicine
|
July 14, 2016
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer
Hope S Rugo, Olufunmilayo I Olopade, Angela DeMichele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 9, 2023
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial
Georg Pfeiler, Dominik Hlauschek, Erica L Mayer, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 230) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 230 results.
JAMA Oncology
|
March 9, 2023
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial
Tufia C Haddad, Vera J Suman, Antonino B D'Assoro, et al.
Cancer
|
April 25, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot
Amye J Tevaarwerk, Dhauna Karam, Clare A Gatten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
Siddhartha Yadav, Chunling Hu, Steven N Hart, et al.
Breast Cancer Research : BCR
|
January 31, 2024
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer
Filipa Lynce, Laura E Stevens, Zheqi Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2022
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
Erica L Mayer, Christian Fesl, Dominik Hlauschek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2021
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
Michael Gnant, Amylou C Dueck, Sophie Frantal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
Angela DeMichele, Douglas Yee, Donald A Berry, et al.
The New England Journal of Medicine
|
July 14, 2016
Adaptive Randomization of Neratinib in Early Breast Cancer
John W Park, Minetta C Liu, Douglas Yee, et al.
The New England Journal of Medicine
|
July 14, 2016
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer
Hope S Rugo, Olufunmilayo I Olopade, Angela DeMichele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 9, 2023
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial
Georg Pfeiler, Dominik Hlauschek, Erica L Mayer, et al.
Page
of 23